Geode Capital Management’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
VCM
CAM
BL
S
VFT
MFIM
Geode Capital Management's ICCC Position: Q1 2026 in Review
Geode Capital Management reduced its ImmuCell (ICCC) stake by 9% in Q1 2026, selling an estimated $41.5K and leaving 65,765 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #3651.
Geode Capital Management first reported a position in ICCC in Q1 2020 and has held it in 25 quarters since. The position peaked at $500K in Q2 2025. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.
- Geode Capital Management held 65,765 shares of ImmuCell worth $416K as of Q1 2026.
- Geode Capital Management sold 6,492 ImmuCell shares in Q1 2026, an estimated $41.5K.
- ImmuCell made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3651 holding.
- Geode Capital Management first reported a position in ImmuCell in Q1 2020 and has held it in 25 quarters since.
- Geode Capital Management's ImmuCell position peaked at $500K in Q2 2025.
- 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.